US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Telomir Pharmaceuticals

2.15

+0.14006.97%

Post-market: 2.160.0100+0.47%19:25 EDT

Volume:182.16K

Turnover:380.32K

Market Cap:63.99M

PE:-5.18

High:2.15

Open:2.07

Low:2.01

Close:2.01

Loading ...

Overview Company News Filings

Telomir Pharmaceuticals-New Data From Preclinical Study of Its Lead Compound, Telomir-1, in Validated Animal Model of Werner Syndrome

THOMSON REUTERS

Telomir Pharmaceuticals- Announces Telomir-1 Resets Epigenetic Clock, Reverses DNA Methylation - SEC Filing

THOMSON REUTERS

Telomir Pharmaceuticals Unveils Promising Preclinical Study Results of Telomir-1 Showing Potential to Reverse Aging Effects in Werner Syndrome Model

Telomir Pharmaceuticals Announces Upcoming Clinical Trials for Telomir-1, Aiming to Tackle Aging and Rare Diseases

Telomir Pharmaceuticals Announces Promising Preclinical Results for Telomir-1 in Treating Age-Related Macular Degeneration

BRIEF-Telomir Pharmaceuticals Inc - Michelle Yanez Steps Down As CFO Of Telomir Pharmaceuticals - SEC Filing

Telomir Pharmaceuticals Appoints New Chief Financial Officer

Telomir Pharmaceuticals Inc - Appoints Alan Weichselbaum as CFO - SEC Filing

THOMSON REUTERS

Telomir Pharmaceuticals Obtains $3 Million in Straight Equity Sale

MT Newswires Live

Telomir Pharmaceuticals announces $3M in equity financing

Telomir Pharmaceuticals Secures $3M Equity Financing Boost

Telomir Pharmaceuticals Secures $3M Through Equity Sale at Premium, Following Prior $1M Investment

Telomir Pharmaceuticals Unveils Promising Antimicrobial Drug Candidate

Telomir Pharmaceuticals Says Telomir-1 Reduces Tumor Size in Prostate Cancer Animal Model

MT Newswires Live

Telomir Pharmaceuticals Announces Significant Anti-Cancer Effects in Prostate Cancer Animal Model Using Highly Aggressive Human Prostate Cancer Cells

ACCESS Newswire

Telomir Pharmaceuticals Inc - Telomir-1 Reduces Tumor Size by Approximately 50% in Preclinical Study

THOMSON REUTERS

Telomir Pharmaceuticals - Announces Significant Anti-Cancer Effects in Prostate Cancer Animal Model

THOMSON REUTERS

TELO Study Shows Cancer-Related Breakthrough

Zacks Small Cap Research

Telomir Pharmaceuticals Announces Breakthrough: Telomir-1 Reverses Calcium Dysregulation, the Hidden Driver of Aging and Disease, in Multiple Human Cell Lines

ACCESS Newswire

Telomir Pharmaceuticals Inc - Telomir-1 Reduces Intracellular Calcium Overload & Mitigates Oxidative Stress

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/TELO/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TELO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TELO\",,,,,undefined,":{"symbol":"TELO","market":"US","secType":"STK","nameCN":"Telomir Pharmaceuticals","latestPrice":2.15,"timestamp":1749240000000,"preClose":2.01,"halted":0,"volume":182156,"hourTrading":{"tag":"盘后","latestPrice":2.16,"preClose":2.15,"latestTime":"19:25 EDT","volume":278,"amount":590.687,"timestamp":1749252308896},"delay":0,"floatShares":17618248,"shares":29762671,"eps":-0.414741,"marketStatus":"Market Closed","change":0.14,"latestTime":"06-06 16:00:00 EDT","open":2.07,"high":2.15,"low":2.0065,"amount":380319.03136240004,"amplitude":0.071393,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.414741,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1749456000000},"marketStatusCode":7,"adr":0,"listingDate":1707454800000,"exchange":"NASDAQ","adjPreClose":2.01,"preHourTrading":{"tag":"盘前","latestPrice":2.07,"preClose":2.01,"latestTime":"08:56 EDT","volume":7309,"amount":14719.429916600002,"timestamp":1749214610122},"postHourTrading":{"tag":"盘后","latestPrice":2.16,"preClose":2.15,"latestTime":"19:25 EDT","volume":278,"amount":590.687,"timestamp":1749252308896},"volumeRatio":0.4108868457844474},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TELO\",,,,,undefined,":{"symbol":"TELO","floatShares":17618248,"roa":"-391.62%","roe":"-872.57%","lyrEps":-0.559686,"volumeRatio":0.4108868457844474,"shares":29762671,"dividePrice":0,"high":2.15,"amplitude":0.071393,"preClose":2.01,"low":2.0065,"week52Low":1.87,"pbRate":"-397.19","week52High":8.4,"institutionHeld":0,"latestPrice":2.15,"eps":-0.414741,"divideRate":0,"volume":182156,"delay":0,"ttmEps":-0.414741,"open":2.07,"prevYearClose":4.12,"prevWeekClose":1.945,"prevMonthClose":1.945,"prevQuarterClose":3.23,"fiveDayClose":1.945,"twentyDayClose":2.52,"sixtyDayClose":4.94},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TELO\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2541402024","title":"Telomir Pharmaceuticals-New Data From Preclinical Study of Its Lead Compound, Telomir-1, in Validated Animal Model of Werner Syndrome","url":"https://stock-news.laohu8.com/highlight/detail?id=2541402024","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541402024?lang=en_us&edition=fundamental","pubTime":"2025-06-05 20:22","pubTimestamp":1749126165,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250605:nFWN3S807G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TELO","BK4007"],"gpt_icon":0},{"id":"2541241020","title":"Telomir Pharmaceuticals- Announces Telomir-1 Resets Epigenetic Clock, Reverses DNA Methylation - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2541241020","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541241020?lang=en_us&edition=fundamental","pubTime":"2025-06-05 20:22","pubTimestamp":1749126165,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250605:nFWN3S807G:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","TELO"],"gpt_icon":0},{"id":"2541027722","title":"Telomir Pharmaceuticals Unveils Promising Preclinical Study Results of Telomir-1 Showing Potential to Reverse Aging Effects in Werner Syndrome Model","url":"https://stock-news.laohu8.com/highlight/detail?id=2541027722","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541027722?lang=en_us&edition=fundamental","pubTime":"2025-06-05 20:01","pubTimestamp":1749124874,"startTime":"0","endTime":"0","summary":"Telomir Pharmaceuticals Unveils Promising Preclinical Study Results of Telomir-1 Showing Potential to Reverse Aging Effects in Werner Syndrome Model. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Telomir Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 05, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250605:nNDLcb9xqM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","TELO"],"gpt_icon":0},{"id":"2540760747","title":"Telomir Pharmaceuticals Announces Upcoming Clinical Trials for Telomir-1, Aiming to Tackle Aging and Rare Diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2540760747","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540760747?lang=en_us&edition=fundamental","pubTime":"2025-06-02 20:01","pubTimestamp":1748865690,"startTime":"0","endTime":"0","summary":"Telomir Pharmaceuticals Inc.  has announced its participation in the upcoming BIO International Convention 2025 in Boston, Massachusetts, scheduled from June 16-19, 2025. The company plans to engage in BIO One-on-One Partnering meetings to explore potential licensing, strategic collaborations, and M&A opportunities. Additionally, Telomir provided updates on its lead candidate, Telomir-1, which is designed to elongate telomeres, regenerate cells, and address key drivers of biological aging. The company is preparing for an Investigational New Drug  submission by the end of the year and anticipates initiating first-in-human clinical trials in the first half of 2026. Telomir also reported preclinical progress in areas such as retinal regeneration, lifespan extension, Type 2 diabetes reversal, and anti-cancer effects. Furthermore, Telomir is launching a rare disease development initiative targeting conditions like Werner's syndrome, Wilson's disease, Progeria, and dysphonia.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250602:nNDL2w0B8x:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","TELO"],"gpt_icon":0},{"id":"2539257705","title":"Telomir Pharmaceuticals Announces Promising Preclinical Results for Telomir-1 in Treating Age-Related Macular Degeneration","url":"https://stock-news.laohu8.com/highlight/detail?id=2539257705","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539257705?lang=en_us&edition=fundamental","pubTime":"2025-05-29 20:01","pubTimestamp":1748520064,"startTime":"0","endTime":"0","summary":"Telomir Pharmaceuticals Inc. has announced promising preclinical results from its ongoing development of Telomir-1, an investigational oral small molecule candidate for treating age-related macular degeneration . The study utilized the Sen57wrn-/-ND6-/+ zebrafish model, which reflects key features of dry AMD and geographic atrophy observed in humans. Over a 14-day period, Telomir-1 was administered orally to 18-month-old animals. The treatment resulted in improved central vision response and motion detection, regeneration of several critical retinal layers, and a reduction in oxidative stress. Notably, untreated animals experienced a 15% mortality rate, while no mortality was observed in the Telomir-1 treated groups. These findings are considered a significant preclinical milestone that supports the continued advancement of Telomir-1 towards an Investigational New Drug  submission.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250529:nNDL9WDV7L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","TELO"],"gpt_icon":0},{"id":"2537520249","title":"BRIEF-Telomir Pharmaceuticals Inc - Michelle Yanez Steps Down As CFO Of Telomir Pharmaceuticals - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2537520249","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537520249?lang=en_us&edition=fundamental","pubTime":"2025-05-22 06:42","pubTimestamp":1747867341,"startTime":"0","endTime":"0","summary":"BRIEF-Telomir Pharmaceuticals Inc - Michelle Yanez Steps Down As CFO Of Telomir Pharmaceuticals - SEC FilingTelomir Pharmaceuticals Inc TELO.O:TELOMIR PHARMACEUTICALS INC - MICHELLE YANEZ STEPS DOWN AS CFO OF TELOMIR PHARMACEUTICALS - SEC FILINGTELOMIR PHARMACEUTICALS INC - APPOINTS ALAN WEICHSELBAUM AS CFO - SEC FILINGSource text: [ID:n0001641172-25-011938]Further company coverage: TELO.O","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250521:nFWN3RT2WO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TELO"],"gpt_icon":0},{"id":"2537525749","title":"Telomir Pharmaceuticals Appoints New Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2537525749","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537525749?lang=en_us&edition=fundamental","pubTime":"2025-05-22 05:49","pubTimestamp":1747864151,"startTime":"0","endTime":"0","summary":"The latest update is out from Telomir Pharmaceuticals, Inc. ( ($TELO) ). On May 16, 2025, Telomir Pharmaceuticals, Inc. announced the mutual resign...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/telomir-pharmaceuticals-appoints-new-chief-financial-officer?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/telomir-pharmaceuticals-appoints-new-chief-financial-officer?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","TELO"],"gpt_icon":0},{"id":"2537954192","title":"Telomir Pharmaceuticals Inc - Appoints Alan Weichselbaum as CFO - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2537954192","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537954192?lang=en_us&edition=fundamental","pubTime":"2025-05-22 05:26","pubTimestamp":1747862784,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250521:nFWN3RT2WO:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","TELO"],"gpt_icon":0},{"id":"2537939154","title":"Telomir Pharmaceuticals Obtains $3 Million in Straight Equity Sale","url":"https://stock-news.laohu8.com/highlight/detail?id=2537939154","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537939154?lang=en_us&edition=fundamental","pubTime":"2025-05-21 22:07","pubTimestamp":1747836462,"startTime":"0","endTime":"0","summary":"Telomir Pharmaceuticals  said Wednesday it has obtained $3 million in equity financing through a direct investment from its largest shareholder The Bayshore Trust.The deal, which involved the purchase of 1 million Telomir restricted shares at $3 apiece, was structured as a straight stock transaction with no warrants, discounts, and convertible features, the company said.Telomir said the investment will fund its upcoming submission of its investigational new drug application for a rare disease indication.Shares of the company fell 3.1% in recent trading.Price: 2.22, Change: -0.07, Percent Change: -3.10","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","BK4215","EQR","BK4007","BK4585","TELO"],"gpt_icon":0},{"id":"2537239935","title":"Telomir Pharmaceuticals announces $3M in equity financing","url":"https://stock-news.laohu8.com/highlight/detail?id=2537239935","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537239935?lang=en_us&edition=fundamental","pubTime":"2025-05-21 21:21","pubTimestamp":1747833670,"startTime":"0","endTime":"0","summary":"Telomir has secured $3M in equity financing, through a direct investment by The Bayshore Trust, the Company’s largest shareholder. The transaction ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/telomir-pharmaceuticals-announces-3m-in-equity-financing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/telomir-pharmaceuticals-announces-3m-in-equity-financing?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1093756325.SGD","BK4534","BK4206","TELO","BK4533","BK4585","LU0787776722.HKD","BK4588","LU1093756168.USD","BK4007","BK4512","LU0683600562.USD","LU1894683348.USD","MMM","SG9999002224.SGD","SG9999002232.USD","LU1894683264.USD"],"gpt_icon":0},{"id":"2537354269","title":"Telomir Pharmaceuticals Secures $3M Equity Financing Boost","url":"https://stock-news.laohu8.com/highlight/detail?id=2537354269","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537354269?lang=en_us&edition=fundamental","pubTime":"2025-05-21 21:18","pubTimestamp":1747833497,"startTime":"0","endTime":"0","summary":"Telomir Pharmaceuticals, Inc. ( ($TELO) ) has provided an announcement. On May 19, 2025, Telomir Pharmaceuticals secured $3 million in equity finan...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/telomir-pharmaceuticals-secures-3m-equity-financing-boost?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/telomir-pharmaceuticals-secures-3m-equity-financing-boost?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0683600562.USD","SG9999002232.USD","SG9999002224.SGD","BK4007","BK4533","LU1093756325.SGD","LU1894683264.USD","BK4206","LU0787776722.HKD","BK4512","LU1894683348.USD","EQR","BK4588","LU1093756168.USD","BK4534","BK4585","MMM","BK4215","TELO"],"gpt_icon":0},{"id":"2537933802","title":"Telomir Pharmaceuticals Secures $3M Through Equity Sale at Premium, Following Prior $1M Investment","url":"https://stock-news.laohu8.com/highlight/detail?id=2537933802","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537933802?lang=en_us&edition=fundamental","pubTime":"2025-05-21 20:46","pubTimestamp":1747831571,"startTime":"0","endTime":"0","summary":"Telomir Pharmaceuticals Inc. has completed a $3 million equity financing through a direct investment by The Bayshore Trust, issuing 1 million restricted shares at $3.00 per share, an 18% premium to the closing price on May 19, 2025. Previously, on December 9, 2024, a $1 million equity investment was made by The Starwood Trust, with shares priced at $7.00 each. Both trusts are affiliated with the company's largest shareholder.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Telomir Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 21, 2025, and is solely responsible f","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250521:nNDLc1xZXY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TELO","BK4007"],"gpt_icon":0},{"id":"2535842060","title":"Telomir Pharmaceuticals Unveils Promising Antimicrobial Drug Candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=2535842060","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535842060?lang=en_us&edition=fundamental","pubTime":"2025-05-15 20:16","pubTimestamp":1747311390,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Telomir Pharmaceuticals, Inc. ( ($TELO) ). On May 15, 2025, Telomir Pharmaceuticals announced the identificatio...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/telomir-pharmaceuticals-unveils-promising-antimicrobial-drug-candidate?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/telomir-pharmaceuticals-unveils-promising-antimicrobial-drug-candidate?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TELO","BK4007"],"gpt_icon":0},{"id":"2520338751","title":"Telomir Pharmaceuticals Says Telomir-1 Reduces Tumor Size in Prostate Cancer Animal Model","url":"https://stock-news.laohu8.com/highlight/detail?id=2520338751","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520338751?lang=en_us&edition=fundamental","pubTime":"2025-03-19 21:31","pubTimestamp":1742391082,"startTime":"0","endTime":"0","summary":"Telomir Pharmaceuticals  said Wednesday that preclinical findings showed that Telomir-1 reduces tumor size by 50% in a prostate cancer animal model using \"highly aggressive\" human prostate cancer cells.Telomir-1 \"actively suppresses cancer growth rather than promoting it, and protects against chemotherapy-induced toxicity and mortality when combined with Paclitaxel,\" a chemotherapy drug that is often linked with severe toxicity and side effects, the company said.Telomir said it is advancing Telomir-1 in several indications in addition to oncology. Studies are assessing the drug in age-related diseases like age-related macular degeneration and Wilson's disease, the company said.The company said it plans to file an investigational new drug application by the end of the year.Telomir shares were up 4% in recent Wednesday premarket activity.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","TELO"],"gpt_icon":0},{"id":"2520814821","title":"Telomir Pharmaceuticals Announces Significant Anti-Cancer Effects in Prostate Cancer Animal Model Using Highly Aggressive Human Prostate Cancer Cells","url":"https://stock-news.laohu8.com/highlight/detail?id=2520814821","media":"ACCESS Newswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520814821?lang=en_us&edition=fundamental","pubTime":"2025-03-19 20:00","pubTimestamp":1742385600,"startTime":"0","endTime":"0","summary":"Telomir-1 Inhibits Tumor Growth, Suppresses Cancer Progression, and Neutralizes Chemotherapy Toxicity. MIAMI, FLORIDA / ACCESS Newswire / March 19, 2025 / Telomir Pharmaceuticals, Inc.  , a leader in age-reversal science, today announced groundbreaking preclinical findings demonstrating that Telomir-1 reduces tumor size by approximately 50% in a prostate cancer animal model using highly aggressive human prostate cancer cells. It was found that Telomir-1 actively suppresses cancer growth rather than promoting it, and protects against chemotherapy-induced toxicity and mortality when combined with Paclitaxel-a widely used chemotherapy drug known for its effectiveness in treating various cancers but often associated with severe toxicity and side effects.Telomir-1 alone at both low and high doses reduced tumor growth by approximately 50%.Contrary to concerns that telomere-elongating drugs may promote cancer, Telomir-1 demonstrated the opposite effect-actively suppressing tumor development, ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/telomir-pharmaceuticals-announces-significant-anti-120000455.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1316542783.SGD","LU2458330169.SGD","LU2360106780.USD","BK4141","LU0056508442.USD","LU0642271901.SGD","LU0823421333.USD","IE00BMPRXR70.SGD","LU1988902786.USD","BK4573","BK4007","LU1803068979.SGD","LU1303367103.USD","LU1951200564.SGD","LU0081259029.USD","IE0004445239.USD","BK4612","BK4529","LU2264538146.SGD","BK4543","LU1923623000.USD","LU0082616367.USD","LU0390134368.USD","LU0979878070.USD","BK4614","LU1242518931.SGD","IE00B5949003.HKD","LU1880398471.USD","LU1064131342.USD","BK4512","BK4554","BK4575","BK4605","BK4588","LU2054465674.USD","BK4534","BK4585","LU0127658192.USD","LU1989764664.SGD","IE00BMPRXN33.USD","LU2098885051.SGD","LU0719512351.SGD","LU1951198990.SGD","BK4532","BK4566","LU1242518857.USD","TELO","LU1852331112.SGD","LU0109392836.USD"],"gpt_icon":1},{"id":"2520902065","title":"Telomir Pharmaceuticals Inc - Telomir-1 Reduces Tumor Size by Approximately 50% in Preclinical Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2520902065","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520902065?lang=en_us&edition=fundamental","pubTime":"2025-03-19 19:32","pubTimestamp":1742383932,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250319:nFWN3Q20I5:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TELO","BK4007"],"gpt_icon":0},{"id":"2520058902","title":"Telomir Pharmaceuticals - Announces Significant Anti-Cancer Effects in Prostate Cancer  Animal Model","url":"https://stock-news.laohu8.com/highlight/detail?id=2520058902","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520058902?lang=en_us&edition=fundamental","pubTime":"2025-03-19 19:32","pubTimestamp":1742383932,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250319:nFWN3Q20I5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","TELO"],"gpt_icon":0},{"id":"2520649134","title":"TELO Study Shows Cancer-Related Breakthrough","url":"https://stock-news.laohu8.com/highlight/detail?id=2520649134","media":"Zacks Small Cap Research","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520649134?lang=en_us&edition=fundamental","pubTime":"2025-03-19 18:08","pubTimestamp":1742378880,"startTime":"0","endTime":"0","summary":"Telomir Pharmaceuticals  is a preclinical stage biopharmaceutical company developing a product designed to lengthen the DNA’s protective telomere caps. Previously reported preclinical tests have shown evidence that Telomir-1, the company’s primary therapy, can lengthen telomeres and initial animal testing illustrates the potential impact. In fact, the company recently released results from one of those tests, which, according to CEO Erez Aminov, “confirms Telomir-1 can reverse biologic aging, extending life while preserving health.”It's this extensive experience and record of success, combined with the test results we’ve seen at this stage of the process that makes us get excited about the potential for Telomir-1 and the company that develops it. We urge investors who hav","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/telo-study-shows-cancer-related-100800765.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TELO","BK4007"],"gpt_icon":0},{"id":"2514083034","title":"Telomir Pharmaceuticals Announces Breakthrough: Telomir-1 Reverses Calcium Dysregulation, the Hidden Driver of Aging and Disease, in Multiple Human Cell Lines","url":"https://stock-news.laohu8.com/highlight/detail?id=2514083034","media":"ACCESS Newswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514083034?lang=en_us&edition=fundamental","pubTime":"2025-02-26 21:00","pubTimestamp":1740574800,"startTime":"0","endTime":"0","summary":"New Study Confirms Telomir-1 Also Reverses Oxidative Stress, Preserves Cellular Integrity, and Prevents Cell Death by Protecting Mitochondria-The Cell's Power Source and Gatekeeper of Life and Death. MIAMI, FLORIDA / ACCESS Newswire / February 26, 2025 / Telomir Pharmaceuticals, Inc.  , a leader in age-reversal science, today announced compelling new preclinical findings demonstrating that Telomir-1 fully reverses calcium dysregulation-an often-overlooked yet fundamental driver of cell death, aging, and disease progression-in multiple human cell lines.\". These findings build upon prior research showing that Telomir-1 also fully reverses oxidative stress , reinforcing its potential as a broad-spectrum therapeutic for aging-related diseases. By restoring intracellular calcium balance, reducing oxidative stress, and protecting mitochondrial integrity and functions, Telomir-1 may directly prevent cellular damage at the root cause, addressing the fundamental mechanisms that drive neurodegen","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/telomir-pharmaceuticals-announces-breakthrough-telomir-130000187.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"Telomir Pharmaceuticals Announces Breakthrough: Telomir-1 Reverses Calcium Dysregulation, the Hidden Driver of Aging and Disease, in Multiple Human Cell Lines","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1951198990.SGD","LU2360106780.USD","LU0823434583.USD","TELO","IE0009356076.USD","LU1880398471.USD","BK4585","LU2250418816.HKD","LU0081259029.USD","IE00B5949003.HKD","IE00BMPRXN33.USD","BK4566","LU0823421333.USD","BK4554","LU1852331112.SGD","LU1803068979.SGD","LU2054465674.USD","LU1242518857.USD","LU1951200564.SGD","LU2098885051.SGD","BK4141","LU2264538146.SGD","BK4512","LU1989764664.SGD","BK4534","LU0082616367.USD","BK4532","BK4543","BK4573","IE00BMPRXR70.SGD","LU0390134368.USD","LU0056508442.USD","LU0127658192.USD","LU1064131342.USD","LU1880398554.USD","LU0889565833.HKD","LU1303367103.USD","BK4007","LU1923623000.USD","BK4575","BK4605","LU0198837287.USD","LU1242518931.SGD","LU0823421416.USD","LU0823434740.USD","LU0109392836.USD","LU0719512351.SGD","LU1988902786.USD","LU0979878070.USD"],"gpt_icon":1},{"id":"2514041501","title":"Telomir Pharmaceuticals Inc - Telomir-1 Reduces Intracellular Calcium Overload & Mitigates Oxidative Stress","url":"https://stock-news.laohu8.com/highlight/detail?id=2514041501","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514041501?lang=en_us&edition=fundamental","pubTime":"2025-02-26 05:10","pubTimestamp":1740517846,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250225:nFWN3PG0JF:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TELO","BK4007"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":52,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TELO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-14","symbol":"TELO","fiscalQuarterEnding":"2025/03","expectedEps":-0.1,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747195200000,"reportTimeType":"post","actualEps":-0.07},{"market":"US","date":"2025-02-04","symbol":"TELO","fiscalQuarterEnding":"2024/12","expectedEps":-0.05,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1738645200000,"reportTimeType":"post","actualEps":-0.1},{"market":"US","date":"2024-11-12","symbol":"TELO","fiscalQuarterEnding":"2024/09","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"post","actualEps":-0.2}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TELO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TELO\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/TELO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"TELO","date":"2025-06-06","current":-4.801996,"percent":0.930303,"low":-83.265127,"twenty":-11.15375,"median":-7.4411,"eighty":-5.738446,"high":-4.268373,"avg":-12.39152,"sd":14.41331,"marketCap":59822968},"quantilePoints":[{"date":"2024-02-16","current":-56.39638,"twenty":-61.770129,"median":-49.049457,"eighty":-41.982417,"marketCap":238655100},{"date":"2024-02-23","current":-62.343889,"twenty":-63.029602,"median":-60.594622,"eighty":-46.922348,"marketCap":263823442},{"date":"2024-03-01","current":-63.46342,"twenty":-63.421438,"median":-62.588787,"eighty":-53.457611,"marketCap":268561012},{"date":"2024-03-08","current":-60.874505,"twenty":-63.351467,"median":-62.553802,"eighty":-58.915325,"marketCap":257605381},{"date":"2024-03-15","current":-45.550923,"twenty":-63.197532,"median":-61.749139,"eighty":-48.657621,"marketCap":192759889},{"date":"2024-03-22","current":-47.510102,"twenty":-63.029602,"median":-60.594622,"eighty":-45.928765,"marketCap":201050637},{"date":"2024-03-28","current":-35.580099,"twenty":-62.973626,"median":-56.39638,"eighty":-42.472212,"marketCap":150565904},{"date":"2024-04-05","current":-16.558518,"twenty":-62.833684,"median":-48.559663,"eighty":-36.881554,"marketCap":216450701},{"date":"2024-04-12","current":-18.574281,"twenty":-62.595784,"median":-46.390571,"eighty":-17.881143,"marketCap":242800474},{"date":"2024-04-19","current":-18.007992,"twenty":-62.469837,"median":-45.480952,"eighty":-18.234508,"marketCap":235398021},{"date":"2024-04-26","current":-15.402836,"twenty":-62.287913,"median":-41.632564,"eighty":-16.272973,"marketCap":201343774},{"date":"2024-05-03","current":-15.493668,"twenty":-61.8401,"median":-38.868721,"eighty":-15.530047,"marketCap":202531127},{"date":"2024-05-10","current":-14.814122,"twenty":-61.126399,"median":-34.985348,"eighty":-15.280653,"marketCap":193648183},{"date":"2024-05-17","current":-9.713938,"twenty":-60.762552,"median":-20.205194,"eighty":-14.460757,"marketCap":183044909},{"date":"2024-05-24","current":-9.899514,"twenty":-60.034856,"median":-18.959358,"eighty":-13.282876,"marketCap":186541828},{"date":"2024-05-31","current":-9.506677,"twenty":-58.635442,"median":-18.087272,"eighty":-12.474215,"marketCap":179139374},{"date":"2024-06-07","current":-8.846709,"twenty":-55.220872,"median":-16.988785,"eighty":-10.175947,"marketCap":166703252},{"date":"2024-06-14","current":-8.642433,"twenty":-50.224965,"median":-16.082609,"eighty":-9.764378,"marketCap":162853977},{"date":"2024-06-21","current":-8.249595,"twenty":-49.049457,"median":-15.652229,"eighty":-9.506677,"marketCap":155451523},{"date":"2024-06-28","current":-7.558201,"twenty":-48.069868,"median":-15.505107,"eighty":-8.846709,"marketCap":142423205},{"date":"2024-07-05","current":-6.803952,"twenty":-47.622055,"median":-15.431264,"eighty":-8.793283,"marketCap":128210494},{"date":"2024-07-12","current":-6.489682,"twenty":-46.614477,"median":-14.995334,"eighty":-8.611006,"marketCap":122288531},{"date":"2024-07-19","current":-5.892568,"twenty":-46.222641,"median":-14.134574,"eighty":-8.227596,"marketCap":111036802},{"date":"2024-07-26","current":-6.096844,"twenty":-45.67687,"median":-13.432376,"eighty":-7.822188,"marketCap":114886078},{"date":"2024-08-02","current":-5.248314,"twenty":-45.438969,"median":-12.639572,"eighty":-6.797667,"marketCap":98896778},{"date":"2024-08-09","current":-6.741098,"twenty":-44.067543,"median":-12.367753,"eighty":-6.690814,"marketCap":127026102},{"date":"2024-08-16","current":-6.303607,"twenty":-42.052388,"median":-10.284417,"eighty":-6.64996,"marketCap":118143157},{"date":"2024-08-23","current":-8.29422,"twenty":-40.401079,"median":-9.899514,"eighty":-6.678244,"marketCap":155451523},{"date":"2024-08-30","current":-8.278421,"twenty":-39.141606,"median":-9.736016,"eighty":-6.690814,"marketCap":155155425},{"date":"2024-09-06","current":-8.136234,"twenty":-38.861724,"median":-9.674022,"eighty":-6.712813,"marketCap":152490542},{"date":"2024-09-13","current":-9.589698,"twenty":-36.881554,"median":-9.506677,"eighty":-6.734812,"marketCap":179731570},{"date":"2024-09-20","current":-12.386034,"twenty":-35.223248,"median":-9.49882,"eighty":-6.759954,"marketCap":232140941},{"date":"2024-09-27","current":-10.774586,"twenty":-34.271647,"median":-9.637093,"eighty":-6.791381,"marketCap":201938931},{"date":"2024-10-04","current":-8.578593,"twenty":-25.750182,"median":-9.548188,"eighty":-6.888805,"marketCap":160781290},{"date":"2024-10-11","current":-8.009846,"twenty":-20.168951,"median":-9.479108,"eighty":-7.001943,"marketCap":150121756},{"date":"2024-10-18","current":-7.425301,"twenty":-19.534707,"median":-9.44751,"eighty":-7.071981,"marketCap":139166125},{"date":"2024-10-25","current":-7.01454,"twenty":-19.059025,"median":-9.384317,"eighty":-6.903527,"marketCap":131467574},{"date":"2024-11-01","current":-6.714368,"twenty":-18.728312,"median":-9.226332,"eighty":-6.834437,"marketCap":125841709},{"date":"2024-11-08","current":-6.666973,"twenty":-18.282076,"median":-8.941959,"eighty":-6.759954,"marketCap":124953415},{"date":"2024-11-15","current":-4.809979,"twenty":-18.039704,"median":-8.846709,"eighty":-6.708049,"marketCap":110444606},{"date":"2024-11-22","current":-5.467643,"twenty":-17.654627,"median":-8.799568,"eighty":-6.673736,"marketCap":125545611},{"date":"2024-11-29","current":-5.132363,"twenty":-17.074838,"median":-8.768141,"eighty":-6.632216,"marketCap":117847059},{"date":"2024-12-06","current":-8.407791,"twenty":-16.522185,"median":-8.642433,"eighty":-6.569924,"marketCap":193055987},{"date":"2024-12-13","current":-6.737953,"twenty":-16.313655,"median":-8.594391,"eighty":-6.600602,"marketCap":154713889},{"date":"2024-12-20","current":-6.712037,"twenty":-15.964821,"median":-8.461728,"eighty":-6.495967,"marketCap":154118835},{"date":"2024-12-27","current":-6.310352,"twenty":-15.760957,"median":-8.366804,"eighty":-6.403683,"marketCap":144895507},{"date":"2025-01-03","current":-5.856836,"twenty":-15.652229,"median":-8.303377,"eighty":-6.363974,"marketCap":134482072},{"date":"2025-01-10","current":-5.325574,"twenty":-15.570683,"median":-8.28632,"eighty":-6.315537,"marketCap":122283477},{"date":"2025-01-17","current":-6.077115,"twenty":-15.523297,"median":-8.249595,"eighty":-6.288654,"marketCap":139540026},{"date":"2025-01-24","current":-6.517673,"twenty":-15.50282,"median":-8.139601,"eighty":-6.28436,"marketCap":149655935},{"date":"2025-01-31","current":-6.297394,"twenty":-15.473282,"median":-8.073041,"eighty":-6.236001,"marketCap":144597981},{"date":"2025-02-07","current":-7.867,"twenty":-15.425578,"median":-8.088839,"eighty":-6.236001,"marketCap":130062872},{"date":"2025-02-14","current":-7.722981,"twenty":-15.280653,"median":-8.030693,"eighty":-6.247693,"marketCap":127681858},{"date":"2025-02-21","current":-7.038894,"twenty":-15.117652,"median":-7.97035,"eighty":-6.260979,"marketCap":116372043},{"date":"2025-02-28","current":-7.200915,"twenty":-14.922849,"median":-7.899257,"eighty":-6.280067,"marketCap":119050684},{"date":"2025-03-07","current":-7.830995,"twenty":-14.578546,"median":-7.867,"eighty":-6.294726,"marketCap":129467618},{"date":"2025-03-14","current":-8.245048,"twenty":-14.152696,"median":-7.888185,"eighty":-6.298884,"marketCap":136313033},{"date":"2025-03-21","current":-8.209043,"twenty":-13.908059,"median":-7.867,"eighty":-6.302115,"marketCap":135717779},{"date":"2025-03-28","current":-7.110904,"twenty":-13.595467,"median":-7.836063,"eighty":-6.306305,"marketCap":117562550},{"date":"2025-04-04","current":-5.27467,"twenty":-13.332709,"median":-7.821994,"eighty":-6.280067,"marketCap":87204626},{"date":"2025-04-11","current":-4.842615,"twenty":-12.988406,"median":-7.793903,"eighty":-6.226574,"marketCap":80061584},{"date":"2025-04-17","current":-4.464567,"twenty":-12.673549,"median":-7.741272,"eighty":-6.154861,"marketCap":73811424},{"date":"2025-04-25","current":-4.590583,"twenty":-12.555761,"median":-7.674628,"eighty":-6.056383,"marketCap":75894811},{"date":"2025-05-02","current":-4.662592,"twenty":-12.434833,"median":-7.63297,"eighty":-6.012327,"marketCap":77085317},{"date":"2025-05-09","current":-4.48257,"twenty":-12.382378,"median":-7.614926,"eighty":-5.935607,"marketCap":74109050},{"date":"2025-05-16","current":-5.972632,"twenty":-12.227313,"median":-7.558201,"eighty":-5.893196,"marketCap":74406677},{"date":"2025-05-23","current":-5.255916,"twenty":-11.632708,"median":-7.513523,"eighty":-5.862019,"marketCap":65477876},{"date":"2025-05-30","current":-5.017011,"twenty":-11.501318,"median":-7.475136,"eighty":-5.83092,"marketCap":62501609},{"date":"2025-06-06","current":-4.801996,"twenty":-11.15375,"median":-7.4411,"eighty":-5.738446,"marketCap":59822968}],"updateTime":1749408044245}}}